Prosecution Insights
Last updated: November 20, 2026

Kisoji Biotechnology Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Kisoji Biotechnology Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution profile is highly concentrated, involving 1 distinct examiner and 1 distinct art unit. This indicates that the company's current patenting efforts are focused on a specific biological or pharmaceutical innovation within a single technical division. The concentration in 1 distinct art unit suggests that the subject matter is specialized and does not span multiple biotechnology disciplines.

BRISTOL, LYNN ANNE is the busiest examiner for the portfolio, holding 1 busiest examiner pending action. Because the total pending office actions and the busiest examiner pending count are each 1, this examiner is the only official currently reviewing the company's active applications. The presence of only 1 distinct examiner means that the outcome of the portfolio's current prosecution phase depends on the interactions with this official. Practitioners should analyze the historical allowance rates of BRISTOL, LYNN ANNE to better manage the prosecution of this single pending matter.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BRISTOL, LYNN ANNE 1 63.4% +39.7%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17786708 POLYPEPTIDES, PROTEIN COMPLEXES AND METHOD FOR MAKING SAME BRISTOL, LYNN ANNE 20d

Top Art Units

Art UnitApps
1643 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17786708 POLYPEPTIDES, PROTEIN COMPLEXES AND METHOD FOR MAKING SAME BRISTOL, LYNN ANNE 1643 §112 Final Rejection 20d Pending Dec 20, 2022

Managing Kisoji Biotechnology Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Kisoji Biotechnology Inc. have?

Kisoji Biotechnology Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Kisoji Biotechnology Inc. applications?

Lynn Anne Bristol has the most, with 1 of Kisoji Biotechnology Inc.'s pending office actions.

What technology area are Kisoji Biotechnology Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month